Delex Healthcare Group Inc. Stock Analysis BNCM
Bounce Mobile Systems, Inc. engages in the provision of asset management and consultancy services. The company is headquartered in Reno, Nevada. The company offers critical care, anti-infective, anesthesia, and medical devices. Its critical care products include HUMAL, DOBULEX, TOTILAC, NOREPIN, Nicardilex, Glisenit, BETALEX, and AXALINE. Its anti-infective products include FUNGINIL, DELEXIGYL, CEFTREX, CEFTAZIN, and AXAZOLID. Its anesthesia products include EXIB, BUPIVAXINE, IFIMOL, INTRAFEN, KETOROLEX, and TRAMADEX. Its medical device products include Lumify, CX50, Affiniti 30, Affiniti 50, Affiniti CVx, Epiq CVX, Vented Spike + CAIR Drive + Non-Return Valve, Spike with Needle-Free Injection Site for Bag, Infusion Set with Y Connection and Neutraclear (Microdrip), and Infusion Set with Y Connection and Neutraclear (Macrodrip).
Read More Delex Healthcare Group Inc (BNCM) Chart
Key Statistics of Delex Healthcare Group Inc (BNCM)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$0.01Volume
25.33KP/E Ratio (TTM)
-52 Week Range
Market Cap
14.00MAvg. Volume
182.78KDividend Yield
-Financial Metrics & Statements of Delex Healthcare Group Inc (BNCM)
FAQ's for Delex Healthcare Group Inc (BNCM)
- According to Musaffa’s Shariah screening methodology, Delex Healthcare Group Inc (BNCM) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.